Sold as Skin Exposure Reduction Paste Against Chemical Warfare Agents. Every FDA application for this active ingredient.
As of Nov 16, 2026, FDA lists 1 application for Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene (sold as Skin Exposure Reduction Paste Against Chemical Warfare Agents), first approved Feb 17, 2000, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Feb 17, 2000 | Skin Exposure Reduction Paste Against Chemical Warfare AgentsNDA 21084 ยท New molecular entity, new combination | US Army Med Res | 1 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA